188 related articles for article (PubMed ID: 16768662)
1. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia.
Winstock AR; Anderson CM; Sheridan J
Med J Aust; 2006 Jun; 184(11):560-2. PubMed ID: 16768662
[TBL] [Abstract][Full Text] [Related]
2. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
3. National survey of hepatitis testing and vaccination services provided by drug services in England and Wales.
Winstock AR; Sheridan J; Lovell S; Farrell M; Strang J
Eur J Clin Microbiol Infect Dis; 2000 Nov; 19(11):823-8. PubMed ID: 11152306
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.
Bini EJ; Kritz S; Brown LS; Robinson J; Calsyn D; Alderson D; Tracy K; McAuliffe P; Smith C; Rotrosen J
J Subst Abuse Treat; 2012 Jun; 42(4):438-45. PubMed ID: 22035702
[TBL] [Abstract][Full Text] [Related]
5. Audit of bloodborne virus prevention activity with drug users seen in primary care.
Weightman R; Walton R; Bury J
Commun Dis Public Health; 2004 Dec; 7(4):301-5. PubMed ID: 15779794
[TBL] [Abstract][Full Text] [Related]
6. Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.
Orkin C; Flanagan S; Wallis E; Ireland G; Dhairyawan R; Fox J; Nandwani R; O'Connell R; Lascar M; Bulman J; Reeves I; Palfreeman A; Foster GR; Ahmad K; Anderson J; Tong CY; Lattimore S
HIV Med; 2016 Mar; 17(3):222-30. PubMed ID: 26919291
[TBL] [Abstract][Full Text] [Related]
7. Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.
Grogan L; Tiernan M; Geogeghan N; Smyth B; Keenan E
Ir J Med Sci; 2005; 174(2):14-20. PubMed ID: 16094907
[TBL] [Abstract][Full Text] [Related]
8. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.
Gyarmathy VA; Rácz J; Neaigus A; Ujhelyi E
AIDS Educ Prev; 2004 Jun; 16(3):276-87. PubMed ID: 15237056
[TBL] [Abstract][Full Text] [Related]
9. High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study.
Hiva S; Negar K; Mohammad-Reza P; Gholam-Reza G; Mohsen A; Ali-Asghar NG; Mohammed-Jafar S
BMC Public Health; 2020 Jun; 20(1):920. PubMed ID: 32532228
[TBL] [Abstract][Full Text] [Related]
10. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.
Edeh J; Spalding P
J Public Health Med; 2000 Dec; 22(4):531-9. PubMed ID: 11192282
[TBL] [Abstract][Full Text] [Related]
11. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
[TBL] [Abstract][Full Text] [Related]
13. Is there a benefit for health care workers in testing HIV, HCV and HBV in routine before elective arthroplasty?
Winkelmann M; Sorrentino JN; Klein M; Macke C; Mommsen P; Brand S; Schröter C; Krettek C; Zeckey C
Orthop Traumatol Surg Res; 2016 Jun; 102(4):513-6. PubMed ID: 27062330
[TBL] [Abstract][Full Text] [Related]
14. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.
Woldegiorgis AE; Erku W; Medhin G; Berhe N; Legesse M
PLoS One; 2019; 14(12):e0226890. PubMed ID: 31887192
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England.
Lamden KH; Kennedy N; Beeching NJ; Lowe D; Morrison CL; Mallinson H; Mutton KJ; Syed Q
J Infect; 1998 Nov; 37(3):260-9. PubMed ID: 9892530
[TBL] [Abstract][Full Text] [Related]
16. Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.
Strauss SM; Astone JM; Des Jarlais DC; Hagan H
AIDS Patient Care STDS; 2005 Feb; 19(2):78-88. PubMed ID: 15716639
[TBL] [Abstract][Full Text] [Related]
17. Blood borne viral infections among Danish health care workers--frequent blood exposure but low prevalence of infection.
Fisker N; Mygind LH; Krarup HB; Licht D; Georgsen J; Christensen PB
Eur J Epidemiol; 2004; 19(1):61-7. PubMed ID: 15012024
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?
Winter RJ; Dietze PM; Gouillou M; Hellard ME; Robinson P; Aitken CK
J Gastroenterol Hepatol; 2013 Feb; 28(2):314-22. PubMed ID: 23190264
[TBL] [Abstract][Full Text] [Related]
19. Impact of an education campaign on management in pregnancy of women infected with a blood-borne virus.
Giles ML; Garland SM; Grover SR; Lewin SM; Hellard ME
Med J Aust; 2006 Apr; 184(8):389-92. PubMed ID: 16618237
[TBL] [Abstract][Full Text] [Related]
20. [Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) testing among injecting drug users].
Gyarmathy VA; Rácz J
Orv Hetil; 2011 Jan; 152(4):124-30. PubMed ID: 21224188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
